10x Genomics (NASDAQ:TXG) Price Target Lowered to $9.00 at JPMorgan Chase & Co.
10x Genomics (NASDAQ:TXG – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $12.00 to $9.00 in a report issued on Friday,Benzinga reports. The firm currently has a neutral rating on the stock. TXG has been the topic of several other reports. Canaccord Genuity Group cut their price target on shares […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target trimmed by JPMorgan Chase & Co. from $12.00 to $9.00 in a report issued on Friday,Benzinga reports. The firm currently has a neutral rating on the stock. TXG has been the topic of several other reports. Canaccord Genuity Group cut their price target on shares […]
